doc. Mgr. Kamil Paruch, Ph.D.
Associate professor, Department of Chemistry
Correspondence Address:
Kotlářská 267/2, 611 37 Brno
Office: bldg. A08/322
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5477 |
---|---|
E‑mail: |
Total number of publications: 152
2022
-
4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: European Patent Office, state: Germany, patent's number: EP3774795, year: 2022
-
4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11498920, year: 2022
-
CDK11 regulates pre-mRNA splicing by phosphorylation ofSF3B1
NATURE, year: 2022, volume: 609, edition: 7928, DOI
-
Comparing the efficiency of six clearing methods in developing seeds of Arabidopsis thaliana
Plant Reproduction, year: 2022, volume: 35, edition: 4, DOI
-
Geometric Control of Cell Behavior by Biomolecule Nanodistribution
ACS BIOMATERIALS SCIENCE & ENGINEERING, year: 2022, volume: 8, edition: 11, DOI
-
Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma
Nature Communications, year: 2022, volume: 13, edition: 1, DOI
-
Inhibitory kinázy Haspin
Year: 2022
-
Substituted aminothiazoles as inhibitors of nucleases
Publisher: IP Australia, state: Australia, patent's number: AU2019256670, year: 2022
-
Substituted propanamides as inhibitors of nucleases
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11453663, year: 2022
-
Substituted propanamides as inhibitors of nucleases
Publisher: IP Australia, state: Australia, patent's number: AU2019256672, year: 2022